Therapists and clinicians must collaborate to integrate psychedelic therapy into the behavioral health system, engaging professional organizations, providers, payers, and policymakers. Key steps for integration and clinician involvement will be
David Esselman, Sarah Abedi
Dr. Anne Wagner and Dr. Michael Mithoefer discuss therapeutic potential of MDMA for couples, sharing insights from their MDMA-assisted couples therapy trials and ongoing research with Dr. Chandra Khalifian and
Chandra Khalifian, Leslie Morland, Kayla Knopp
Psychedelic-assisted therapies for adolescents are discussed, including the use of ketamine for treatment-resistant depression and the need for further studies and careful consideration of risks. Traditional use of plant medicines
Corine de Boer, Rebecca Kronman, Glauber Assis
Clinical trials show potential of psychedelics for psychiatric treatment, but studies note varied responses. Unclear clinical mechanism discussed in talk on neurobiology and optimizing psychedelic therapy.
Panel explores challenges of managing expectations and risks in psychedelic-assisted therapy amid growing media coverage. Participants, patients, and practitioners often lack information on risks.
David B Yaden, Xiaojue Hu